top of page
Search
  • Mathew Shanley, www.raredr.com
    • Jun 25, 2017
    • 1 min read

Seattle Genetics announced promising results from its Phase 3 ECHELON-1 in Frontline Advanced Hodgki

19 views0 comments
bottom of page